IL-35: A Novel Immunomodulator in Hepatitis B Virus-Related Liver Diseases
Open Access
- 11 March 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
Abstract
Chronic hepatitis B virus (HBV) infection is a risk factor for liver cirrhosis (LC) and hepatocellular carcinoma (HCC), however, little is known about the mechanisms involved in the progression of HBV-related diseases. It has been well acknowledged that host immune response was closely related to the clinical outcomes of patients with HBV infection. As the factors closely related to the immunomodulatory process, cytokines are crucial in the cell-cell communication and the host responses to HBV infection. Recently, a newly discovered cytokine, designated as interleukin-35 (IL-35), has been proved to be essential for the progression of chronic HBV infection, the development of cirrhosis, the transformation of cirrhosis to HCC, and the metastasis of HCC. Specifically, it showed various biological activities such as inhibiting the HBV-specific cytotoxic T lymphocyte (CTL) proliferation and cytotoxicity, deactivating the immature effector T-cells (Teffs), as well as delaying the proliferation of dendritic cells. It regulated the immune responses by acting as a "brake" on the activation of Teffs, which subsequently played important roles in the pathogenesis of various inflammatory diseases and malignancies. In this review, we focused on the most recent data on the relationship between IL-35 and chronic HBV infection, LC and HCC.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 112 references indexed in Scilit:
- Interleukin 35: A Key Mediator of Suppression and the Propagation of Infectious ToleranceFrontiers in Immunology, 2013
- IL-10–Producing Regulatory B Cells in the Pathogenesis of Chronic Hepatitis B Virus InfectionThe Journal of Immunology, 2012
- Serum IL-33 Levels Are Associated with Liver Damage in Patients with Chronic Hepatitis BJournal of Interferon & Cytokine Research, 2012
- T-Regulatory Cells: Key Players in Tumor Immune Escape and AngiogenesisCancer Research, 2012
- IL-35 Is a Novel Responsive Anti-inflammatory Cytokine — A New System of Categorizing Anti-inflammatory CytokinesPLOS ONE, 2012
- The composition and signaling of the IL-35 receptor are unconventionalNature Immunology, 2012
- A Proinflammatory Role for Interleukin-22 in the Immune Response to Hepatitis B VirusGastroenterology, 2011
- IL-35-mediated induction of a potent regulatory T cell populationNature Immunology, 2010
- A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infectionHepatology International, 2010
- The Size of the Viral Inoculum Contributes to the Outcome of Hepatitis B Virus InfectionJournal of Virology, 2009